Literature DB >> 27479817

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres.

Veronika Navrkalova1, Emma Young2, Panagiotis Baliakas2, Lenka Radova3, Lesley-Ann Sutton2, Karla Plevova4, Larry Mansouri2, Viktor Ljungström2, Stavroula Ntoufa5, Zadie Davis6, Gunnar Juliusson7, Karin E Smedby8, Chrysoula Belessi9, Panagiotis Panagiotidis10, Tasoula Touloumenidou11, Frederic Davi12, Anton W Langerak13, Paolo Ghia14, Jonathan C Strefford15, David Oscier6, Jiri Mayer16, Kostas Stamatopoulos5, Sarka Pospisilova4, Richard Rosenquist2, Martin Trbusek17.   

Abstract

Entities:  

Keywords:  ATM mutation; antigenic selection; chronic lymphocytic leukemia; short telomere; stereotyped subset

Mesh:

Substances:

Year:  2016        PMID: 27479817      PMCID: PMC5060033          DOI: 10.3324/haematol.2016.142968

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage.

Authors:  Tatjana Stankovic; Grant S Stewart; Christopher Fegan; Paul Biggs; James Last; Philip J Byrd; Russell D Keenan; Paul A H Moss; Alexander M R Taylor
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

Review 2.  The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia.

Authors:  Lesley-Ann Sutton; Richard Rosenquist
Journal:  Semin Cancer Biol       Date:  2015-05-09       Impact factor: 15.707

3.  Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.

Authors:  Panagiotis Baliakas; Andreas Agathangelidis; Anastasia Hadzidimitriou; Lesley-Ann Sutton; Eva Minga; Athina Tsanousa; Lydia Scarfò; Zadie Davis; Xiao-Jie Yan; Tait Shanafelt; Karla Plevova; Yorick Sandberg; Fie Juhl Vojdeman; Myriam Boudjogra; Tatiana Tzenou; Maria Chatzouli; Charles C Chu; Silvio Veronese; Anne Gardiner; Larry Mansouri; Karin E Smedby; Lone Bredo Pedersen; Denis Moreno; Kirsten Van Lom; Véronique Giudicelli; Hana Skuhrova Francova; Florence Nguyen-Khac; Panagiotis Panagiotidis; Gunnar Juliusson; Lefteris Angelis; Achilles Anagnostopoulos; Marie-Paule Lefranc; Monica Facco; Livio Trentin; Mark Catherwood; Marco Montillo; Christian H Geisler; Anton W Langerak; Sarka Pospisilova; Nicholas Chiorazzi; David Oscier; Diane F Jelinek; Nikos Darzentas; Chrysoula Belessi; Frederic Davi; Paolo Ghia; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood       Date:  2014-12-17       Impact factor: 22.113

4.  Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Valeria Spina; Riccardo Bomben; Silvia Rasi; Michele Dal-Bo; Alessio Bruscaggin; Francesca Maria Rossi; Sara Monti; Massimo Degan; Carmela Ciardullo; Roberto Serra; Antonella Zucchetto; Josep Nomdedeu; Pietro Bulian; Alberto Grossi; Francesco Zaja; Gabriele Pozzato; Luca Laurenti; Dimitar G Efremov; Francesco Di-Raimondo; Roberto Marasca; Francesco Forconi; Giovanni Del Poeta; Gianluca Gaidano; Valter Gattei
Journal:  Blood       Date:  2013-05-01       Impact factor: 22.113

5.  Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients.

Authors:  Larry Mansouri; Pawel Grabowski; Sofie Degerman; Ulrika Svenson; Rebeqa Gunnarsson; Nicola Cahill; Karin Ekström Smedby; Christian Geisler; Gunnar Juliusson; Göran Roos; Richard Rosenquist
Journal:  Am J Hematol       Date:  2013-06-20       Impact factor: 10.047

6.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

7.  Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study.

Authors:  Panagiotis Baliakas; Anastasia Hadzidimitriou; Lesley-Ann Sutton; Eva Minga; Andreas Agathangelidis; Michele Nichelatti; Athina Tsanousa; Lydia Scarfò; Zadie Davis; Xiao-Jie Yan; Tait Shanafelt; Karla Plevova; Yorick Sandberg; Fie Juhl Vojdeman; Myriam Boudjogra; Tatiana Tzenou; Maria Chatzouli; Charles C Chu; Silvio Veronese; Anne Gardiner; Larry Mansouri; Karin E Smedby; Lone Bredo Pedersen; Kirsten van Lom; Véronique Giudicelli; Hana Skuhrova Francova; Florence Nguyen-Khac; Panagiotis Panagiotidis; Gunnar Juliusson; Lefteris Angelis; Achilles Anagnostopoulos; Marie-Paule Lefranc; Monica Facco; Livio Trentin; Mark Catherwood; Marco Montillo; Christian H Geisler; Anton W Langerak; Sarka Pospisilova; Nicholas Chiorazzi; David Oscier; Diane F Jelinek; Nikos Darzentas; Chrysoula Belessi; Frederic Davi; Richard Rosenquist; Paolo Ghia; Kostas Stamatopoulos
Journal:  Lancet Haematol       Date:  2014-11-03       Impact factor: 18.959

8.  Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia.

Authors:  Göran Roos; Alexander Kröber; Pawel Grabowski; Dirk Kienle; Andreas Bühler; Hartmut Döhner; Richard Rosenquist; Stephan Stilgenbauer
Journal:  Blood       Date:  2007-11-28       Impact factor: 22.113

9.  PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations.

Authors:  Jaroslav Bendl; Jan Stourac; Ondrej Salanda; Antonin Pavelka; Eric D Wieben; Jaroslav Zendulka; Jan Brezovsky; Jiri Damborsky
Journal:  PLoS Comput Biol       Date:  2014-01-16       Impact factor: 4.475

10.  Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.

Authors:  J C Strefford; L Kadalayil; J Forster; M J J Rose-Zerilli; A Parker; T T Lin; N Heppel; K Norris; A Gardiner; Z Davies; D Gonzalez de Castro; M Else; A J Steele; H Parker; T Stankovic; C Pepper; C Fegan; D Baird; A Collins; D Catovsky; D G Oscier
Journal:  Leukemia       Date:  2015-08-10       Impact factor: 11.528

View more
  7 in total

1.  Subclonal heterogeneity sheds light on the transformation trajectory in IGLV3-21R110 chronic lymphocytic leukemia.

Authors:  Lisa Paschold; Donjete Simnica; Ramon Benitez Brito; Tianjiao Zhang; Christoph Schultheiß; Christine Dierks; Mascha Binder
Journal:  Blood Cancer J       Date:  2022-03-30       Impact factor: 11.037

Review 2.  Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL.

Authors:  Andreas Agathangelidis; Anastasia Chatzidimitriou; Thomas Chatzikonstantinou; Cristina Tresoldi; Zadie Davis; Véronique Giudicelli; Sofia Kossida; Chrysoula Belessi; Richard Rosenquist; Paolo Ghia; Anton W Langerak; Frédéric Davi; Kostas Stamatopoulos
Journal:  Leukemia       Date:  2022-05-25       Impact factor: 12.883

3.  Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting.

Authors:  Tatjana Pandzic; Claes Ladenvall; Marie Engvall; Mattias Mattsson; Monica Hermanson; Lucia Cavelier; Viktor Ljungström; Panagiotis Baliakas
Journal:  Hemasphere       Date:  2022-08-02

4.  Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.

Authors:  Andreas Agathangelidis; Anastasia Chatzidimitriou; Katerina Gemenetzi; Veronique Giudicelli; Maria Karypidou; Karla Plevova; Zadie Davis; Xiao-Jie Yan; Sabine Jeromin; Christof Schneider; Lone Bredo Pedersen; Renee C Tschumper; Lesley-Ann Sutton; Panagiotis Baliakas; Lydia Scarfò; Ellen J van Gastel; Marine Armand; Eugen Tausch; Bella Biderman; Constance Baer; Davide Bagnara; Alba Navarro; Anne Langlois de Septenville; Valentina Guido; Gerlinde Mitterbauer-Hohendanner; Aleksandar Dimovski; Christian Brieghel; Sarah Lawless; Manja Meggendorfer; Kamila Brazdilova; Matthias Ritgen; Monica Facco; Cristina Tresoldi; Andrea Visentin; Andrea Patriarca; Mark Catherwood; Lisa Bonello; Andrey Sudarikov; Katrina Vanura; Maria Roumelioti; Hana Skuhrova Francova; Theodoros Moysiadis; Silvio Veronese; Krzysztof Giannopoulos; Larry Mansouri; Teodora Karan-Djurasevic; Raphael Sandaltzopoulos; Csaba Bödör; Franco Fais; Arnon P Kater; Irina Panovska; Davide Rossi; Salem Alshemmari; Panagiotis Panagiotidis; Paul Costeas; Blanca Espinet; Darko Antic; Letizia Foroni; Marco Montillo; Livio Trentin; Niki Stavroyianni; Gianluca Gaidano; Paola Francia di Celle; Carsten Niemann; Elias Campo; Achilles Anagnostopoulos; Christiane Pott; Kirsten Fischer; Michael Hallek; David Oscier; Stephan Stilgenbauer; Claudia Haferlach; Diane Jelinek; Nicholas Chiorazzi; Sarka Pospisilova; Marie-Paule Lefranc; Sofia Kossida; Anton W Langerak; Chrysoula Belessi; Frederic Davi; Richard Rosenquist; Paolo Ghia; Kostas Stamatopoulos
Journal:  Blood       Date:  2021-03-11       Impact factor: 22.113

5.  Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations.

Authors:  R Rosenquist; P Ghia; A Hadzidimitriou; L-A Sutton; A Agathangelidis; P Baliakas; N Darzentas; V Giudicelli; M-P Lefranc; A W Langerak; C Belessi; F Davi; K Stamatopoulos
Journal:  Leukemia       Date:  2017-04-25       Impact factor: 11.528

6.  Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia.

Authors:  Veronika Mancikova; Helena Peschelova; Veronika Kozlova; Aneta Ledererova; Adriana Ladungova; Jan Verner; Tomas Loja; Frantisek Folber; Jiri Mayer; Sarka Pospisilova; Michal Smida
Journal:  J Immunother Cancer       Date:  2020-03       Impact factor: 13.751

7.  Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.

Authors:  Helena Olbertova; Karla Plevova; Sarka Pavlova; Jitka Malcikova; Jana Kotaskova; Kamila Stranska; Michaela Spunarova; Martin Trbusek; Veronika Navrkalova; Barbara Dvorackova; Nikola Tom; Karol Pal; Marie Jarosova; Yvona Brychtova; Anna Panovska; Michael Doubek; Sarka Pospisilova
Journal:  BMC Cancer       Date:  2022-02-03       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.